RE:Stephenson comments on CXR CXR-T 2016-04-26 BUY on WEAKNESS John Stephenson
The whole healthcare sector is offering tremendous value because of all this overhang with Valeant (VRX-T) and others. Feels it is an attractive name. Definitely fast growth and will be volatile. He would Hold or Buy on pullbacks.
Login to show your approval Login to show your disapproval / Be the first to comment
Price:
$41.000
Subject:
NORTH AMERICAN
Bias:
UNKNOWN
Owned:
Unknown